A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson's Disease

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Emily Forbes

Emily Forbes

Study ID

Protocol Number: 22-0285

More information available at ClinicalTrials.gov: NCT05348785

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers